Artlett Carol M

Top coauthors of Artlett Carol M

Sassi-Gaha Sihem (8 papers)

Jimenez Sergio A (8 papers)

Thacker James D (4 papers)

Loughlin Danielle T (4 papers)

Long Kristen B (4 papers)

List of Artlett Carol M publications

2016

Sargent Jennifer L, Li Zhenghui, Aliprantis Antonios O, Greenblatt Matthew, Lemaire Raphael, et al. 2016. "Interspecies comparative genomics identifies optimal mouse models of systemic sclerosis." Arthritis & rheumatology (Hoboken, N.J.) doi:10.1002/art.39658

2015

Artlett Carol M, Thacker James D 2015. "Molecular activation of the NLRP3 Inflammasome in fibrosis: common threads linking divergent fibrogenic diseases." Antioxidants & redox signaling 22 (13) doi:10.1089/ars.2014.6148
Long Kristen B, Li Zhenghui, Burgwin Chelsea M, Choe Susanna G, Martyanov Viktor, et al. 2015. "The Tsk2/+ mouse fibrotic phenotype is due to a gain-of-function mutation in the PIIINP segment of the Col3a1 gene." The Journal of investigative dermatology 135 (3) doi:10.1038/jid.2014.455
Artlett Carol M, Sassi-Gaha Sihem, Ramos Ronald C, Miller Frederick W, Rider Lisa G 2015. "Chimeric cells of maternal origin do not appear to be pathogenic in the juvenile idiopathic inflammatory myopathies or muscular dystrophy." Arthritis research & therapy 17 doi:10.1186/s13075-015-0732-0

2014

Long Kristen B, Artlett Carol M, Blankenhorn Elizabeth P 2014. "Tight skin 2 mice exhibit a novel time line of events leading to increased extracellular matrix deposition and dermal fibrosis." Matrix biology : journal of the International Society for Matrix Biology 38 doi:10.1016/j.matbio.2014.05.002
Long Kristen B, Burgwin Chelsea M, Huneke Richard, Artlett Carol M, Blankenhorn Elizabeth P 2014. "Tight Skin 2 Mice Exhibit Delayed Wound Healing Caused by Increased Elastic Fibers in Fibrotic Skin." Advances in wound care 3 (9) doi:10.1089/wound.2014.0529
Overley-Adamson Beth, Artlett Carol M, Stephens Connie, Sassi-Gaha Sihem, Weis Ransome D, Thacker James D 2014. "Targeting the unfolded protein response, XBP1, and the NLRP3 inflammasome in fibrosis and cancer." Cancer biology & therapy 15 (4) doi:10.4161/cbt.27820
Artlett Carol M 2014. "Animal models of systemic sclerosis: their utility and limitations." Open access rheumatology : research and reviews 6 doi:10.2147/OARRR.S50009

2013

Loarca Lorena, Sassi-Gaha Sihem, Artlett Carol M 2013. "Two α-dicarbonyls downregulate migration, invasion, and adhesion of liver cancer cells in a p53-dependent manner." Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 45 (11) doi:10.1016/j.dld.2013.05.005
Artlett Carol M 2013. "Inflammasomes in wound healing and fibrosis." The Journal of pathology 229 (2) doi:10.1002/path.4116

2012

Thacker James D, Balin Brian J, Appelt Denah M, Sassi-Gaha Sihem, Purohit Mitali, et al. 2012. "NLRP3 inflammasome is a target for development of broad-spectrum anti-infective drugs." Antimicrobial agents and chemotherapy 56 (4) doi:10.1128/AAC.06372-11
Artlett Carol M 2012. "The Role of the NLRP3 Inflammasome in Fibrosis." The open rheumatology journal 6 doi:10.2174/1874312901206010080

2011

Artlett Carol M, Sassi-Gaha Sihem, Rieger Judy L, Boesteanu Alina C, Feghali-Bostwick Carol A, Katsikis Peter D 2011. "The inflammasome activating caspase 1 mediates fibrosis and myofibroblast differentiation in systemic sclerosis." Arthritis and rheumatism 63 (11) doi:10.1002/art.30568
Loughlin Danielle T, Artlett Carol M 2011. "Modification of collagen by 3-deoxyglucosone alters wound healing through differential regulation of p38 MAP kinase." PloS one 6 (5) doi:10.1371/journal.pone.0018676

2010

Artlett Carol M 2010. "Animal models of scleroderma: fresh insights." Current opinion in rheumatology 22 (6) doi:10.1097/BOR.0b013e32833e307b
Sassi-Gaha Sihem, Loughlin Danielle T, Kappler Frank, Schwartz Michael L, Su Bangying, et al. 2010. "Two dicarbonyl compounds, 3-deoxyglucosone and methylglyoxal, differentially modulate dermal fibroblasts." Matrix biology : journal of the International Society for Matrix Biology 29 (2) doi:10.1016/j.matbio.2009.09.007
Loughlin Danielle T, Artlett Carol M 2010. "Precursor of advanced glycation end products mediates ER-stress-induced caspase-3 activation of human dermal fibroblasts through NAD(P)H oxidase 4." PloS one 5 (6) doi:10.1371/journal.pone.0011093

2009

Thacker James D, Brown Martyn A, Rest Richard F, Purohit Mitali, Sassi-Gaha Sihem, Artlett Carol M 2009. "1-Peptidyl-2-arachidonoyl-3-stearoyl-sn-glyceride: an immunologically active lipopeptide from goat serum (Capra hircus) is an endogenous damage-associated molecular pattern." Journal of natural products 72 (11) doi:10.1021/np900360m
Loughlin Danielle T, Artlett Carol M 2009. "3-Deoxyglucosone-collagen alters human dermal fibroblast migration and adhesion: implications for impaired wound healing in patients with diabetes." Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society 17 (5) doi:10.1111/j.1524-475X.2009.00532.x

2008

Hoffman William H, Artlett Carol M, Zhang Weixian, Kreipke Christian W, Passmore Gregory G, et al. 2008. "Receptor for advanced glycation end products and neuronal deficit in the fatal brain edema of diabetic ketoacidosis." Brain research 1238 doi:10.1016/j.brainres.2008.08.041
Mueller Yvonne M, Do Duc H, Altork Susan R, Artlett Carol M, Gracely Edward J, et al. 2008. "IL-15 treatment during acute simian immunodeficiency virus (SIV) infection increases viral set point and accelerates disease progression despite the induction of stronger SIV-specific CD8+ T cell responses." Journal of immunology (Baltimore, Md. : 1950) 180 (1) doi:

2006

Del Galdo Francesco, Artlett Carol M, Jimenez Sergio A 2006. "The role of allograft inflammatory factor 1 in systemic sclerosis." Current opinion in rheumatology 18 (6) doi:10.1097/01.bor.0000245724.94887.c4
Derk Chris T, Artlett Carol M, Jimenez Sergio A 2006. "Morbidity and mortality of patients diagnosed with systemic sclerosis after the age of 75: a nested case-control study." Clinical rheumatology 25 (6) doi:10.1007/s10067-005-0177-y
Del Galdo Francesco, Maul Gerd G, Jiménez Sergio A, Artlett Carol M 2006. "Expression of allograft inflammatory factor 1 in tissues from patients with systemic sclerosis and in vitro differential expression of its isoforms in response to transforming growth factor beta." Arthritis and rheumatism 54 (8) doi:10.1002/art.22010
Derk Chris T, Rasheed Mehmoodur, Artlett Carol M, Jimenez Sergio A 2006. "A cohort study of cancer incidence in systemic sclerosis." The Journal of rheumatology 33 (6) doi:
Del Galdo Francesco, Artlett Carol M 2006. "T cells and B cells in the pathogenesis of systemic sclerosis: recent insights and therapeutic opportunities." Current rheumatology reports 8 (2) doi:
Mendoza Fabian A, Artlett Carol M, Sandorfi Nora, Latinis Kevin, Piera-Velazquez Sonsoles, Jimenez Sergio A 2006. "Description of 12 cases of nephrogenic fibrosing dermopathy and review of the literature." Seminars in arthritis and rheumatism 35 (4) doi:10.1016/j.semarthrit.2005.08.002

2005

Artlett Carol M 2005. "Pathophysiology of fetal microchimeric cells." Clinica chimica acta; international journal of clinical chemistry 360 (1-2) doi:10.1016/j.cccn.2005.04.019
Gentiletti Julieta, McCloskey Laura J, Artlett Carol M, Peters Josephine, Jimenez Sergio A, Christner Paul J 2005. "Demonstration of autoimmunity in the tight skin-2 mouse: a model for scleroderma." Journal of immunology (Baltimore, Md. : 1950) 175 (4) doi:
Kowalzick Lutz, Artlett Carol M, Thoss Karin, Baum Hans-Peter, Ziegler Heidrun, et al. 2005. "Chronic graft-versus-host-disease-like dermopathy in a child with CD4+ cell microchimerism." Dermatology (Basel, Switzerland) 210 (1) doi:10.1159/000081489
Jimenez Sergio A, Artlett Carol M 2005. "Microchimerism and systemic sclerosis." Current opinion in rheumatology 17 (1) doi:
Artlett Carol M 2005. "Immunology of systemic sclerosis." Frontiers in bioscience : a journal and virtual library 10 doi:

2004

Jiménez Sergio A, Artlett Carol M, Sandorfi Nora, Derk Chris, Latinis Kevin, et al. 2004. "Dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy): study of inflammatory cells and transforming growth factor beta1 expression in affected skin." Arthritis and rheumatism 50 (8) doi:10.1002/art.20362

2003

Artlett Carol M, O'Hanlon Terrence P, Lopez Ana M, Song Yeong Wook, Miller Frederick W, Rider Lisa G 2003. "HLA-DQA1 is not an apparent risk factor for microchimerism in patients with various autoimmune diseases and in healthy individuals." Arthritis and rheumatism 48 (9) doi:10.1002/art.11235
Artlett Carol M 2003. "Microchimerism and scleroderma: an update." Current rheumatology reports 5 (2) doi:

2002

Artlett Carol M 2002. "Microchimerism in health and disease." Current molecular medicine 2 (6) doi:
Artlett Carol M, Cox Lori A, Ramos Ronald C, Dennis Tara N, Fortunato Richard A, et al. 2002. "Increased microchimeric CD4+ T lymphocytes in peripheral blood from women with systemic sclerosis." Clinical immunology (Orlando, Fla.) 103 (3 Pt 1) doi:
Sakkas Lazaros I, Xu Bin, Artlett Carol M, Lu Song, Jimenez Sergio A, Platsoucas Chris D 2002. "Oligoclonal T cell expansion in the skin of patients with systemic sclerosis." Journal of immunology (Baltimore, Md. : 1950) 168 (7) doi: